Q2 Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Q2 Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $51.70M | Feb 16, 2018 |
| FY2017 | Sep 30, 2017 | $50.12M | Feb 16, 2018 |
| FY2017 | Jun 30, 2017 | $47.63M | Feb 16, 2018 |
| FY2017 | Mar 31, 2017 | $44.53M | Feb 16, 2018 |
| FY2017 | Dec 31, 2016 | $42.16M | Feb 16, 2018 |
| FY2017 | Sep 30, 2016 | $38.31M | Feb 16, 2018 |
| FY2017 | Jun 30, 2016 | $36.01M | Feb 16, 2018 |
| FY2017 | Mar 31, 2016 | $33.76M | Feb 16, 2018 |
| FY2016 | Dec 31, 2015 | $30.41M | Feb 21, 2017 |
| FY2016 | Sep 30, 2015 | $28.02M | Feb 21, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $794.81M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $696.46M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $624.62M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $565.67M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $498.72M | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $108.99M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $103.80M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $97.58M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $92.38M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $86.84M | Feb 19, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $429.68M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $354.48M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $302.65M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $256.35M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $225.04M | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $44.51M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $46.44M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $44.38M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $39.27M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $42.04M | Feb 19, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.01M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | ($38.54M) | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | ($65.38M) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | ($108.98M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | ($112.75M) | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | ($37.82M) | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | ($26.72M) | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | ($38.97M) | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | ($34.11M) | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | ($15.67M) | Feb 19, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.90M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | ($42.26M) | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | ($86.06M) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | ($104.76M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | ($78.00M) | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | ($20.48M) | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | ($19.85M) | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | ($32.31M) | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | ($27.20M) | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | ($21.86M) | Feb 19, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $154.33M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $143.24M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $137.33M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $130.10M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $116.95M | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $25.21M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $23.57M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $23.64M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $24.96M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $19.88M | Feb 19, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $201.46M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $135.75M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $70.29M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $36.56M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $31.09M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | ($2.94M) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $567.0K | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $4.60M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $9.47M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $3.39M | Feb 19, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.81M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $6.69M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $5.67M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $11.14M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $19.75M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $23.72M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $13.86M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $13.29M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $12.32M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $14.35M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.28B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.29B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $1.20B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.35B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $1.39B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.42B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $1.01B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $463.72M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $212.82M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $200.98M | Feb 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $614.47M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $777.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $752.95M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $930.70M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $814.75M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $773.34M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $630.02M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $304.82M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $106.19M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $100.75M | Feb 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $661.81M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $517.80M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $448.48M | Feb 11, 2026 |
| FY2025 | Dec 31, 2022 | $419.02M | Feb 11, 2026 |
| FY2024 | Dec 31, 2021 | $570.30M | Feb 12, 2025 |
| FY2023 | Dec 31, 2020 | $643.36M | Feb 21, 2024 |
| FY2022 | Dec 31, 2019 | $379.41M | Feb 21, 2023 |
| FY2019 | Dec 31, 2018 | $158.90M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $106.62M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $100.24M | Feb 16, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $512.87M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $512.87M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $512.87M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $512.87M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $512.87M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $462.27M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $462.02M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $107.91M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $12.88M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $12.88M | Feb 16, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($612.22M) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | ($664.23M) | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | ($625.69M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | ($560.31M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | ($493.93M) | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | ($381.19M) | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | ($243.30M) | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | ($172.42M) | Feb 21, 2020 |
| FY2018 | Jan 1, 2018 | ($136.27M) | Feb 19, 2019 |
| FY2018 | Dec 31, 2017 | ($152.11M) | Feb 19, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $367.63M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $358.56M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $229.66M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $199.60M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $322.85M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $407.70M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $100.09M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $108.34M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $57.96M | Feb 19, 2019 |
| FY2018 | Dec 31, 2016 | $54.87M | Feb 19, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | (2) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | (1) | Feb 16, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | (2) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | (1) | Feb 16, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 62.74M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 60.73M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 59.03M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 57.74M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 56.93M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | 55.56M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | 48.39M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 43.54M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | 41.97M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | 40.43M | Feb 16, 2018 |